Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats

References

• Chino Y, Minagawa T, Kohno Y, et al. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus. Jpn J Pharmacol 1999;81(1):107–14.
   PubMedGoogle Scholar
• Kreutz RP, Nystrom P, Kreutz Y, et al. Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin. Platelets 2013;24(2):145–50.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu P, Chen L, et al. Prostaglandin E1 encapsulated into lipid nanoparticles improves its anti-inflammatory effect with low side-effect. Int J Pharm 2010;387(1-2):263–71.
   PubMed Web of Science ®Google Scholar
• Matsuo H, Shigematsu H. Patient-based outcomes using the Walking Impairment Questionnaire for patients withperipheral arterial occlusive disease treated with Lipo-PGE1. Circ J. 2010;74(2):365–70.
   PubMed Web of Science ®Google Scholar
• Creutzig A, Lehmacher W, Elze M. Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV. Vasa. 2004;33(3):137–44.
   PubMed Web of Science ®Google Scholar
• Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease. Cardiovasc Res 2002;56(2):214–24.
   PubMed Web of Science ®Google Scholar
• Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium. Biomed Pharmacother 2003;57(3-4):173–8.
   PubMed Web of Science ®Google Scholar
• Han R, Gao B, Sheng R, et al. Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia. Acta Pharmacol Sin 2008;29(10):1141–9.
   PubMed Web of Science ®Google Scholar
• Sheng R, Zhang LS, Han R. et al. Qin, Combined prostaglandin E1 and lithium exert potent neuroprotection in a rat model of cerebral ischemia. Acta Pharmacol Sin 2011;32(3):303–10.
   PubMed Web of Science ®Google Scholar
• Komaba Y, Kitamura S, Terashi A. Effect of prostaglandin E1 on cerebral blood flow in patients with chronic cerebral infarction. Intern Med 1998;37(10):841–6.
   PubMed Web of Science ®Google Scholar
• Huang Y, Marui A, Sakaguchi H, et al. Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia. Circ J 2008;72(10):1693–9.
   PubMed Web of Science ®Google Scholar
• Moreschi D Jr, Fagundes DJ, Hernandes L, et al. Effects of prostaglandin E(1) in the genesis of blood capillaries in the ischemic skeletal muscle of rats: ultrastructural analysis. Ann Vasc Surg 2008;22(1):121–6.
   PubMed Web of Science ®Google Scholar
• Esaki J, Sakaguchi H, Marui A, et al. Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. Circ J 2009;73(7):1330–6.
   PubMed Web of Science ®Google Scholar
• Mehrabi MR, Serbecic N, Tamaddon F, et al. Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart disease. Pathol Res Pract 2003;199(3):129–36.
   PubMed Web of Science ®Google Scholar
• Chen ST, Hsu CY, Hogan EL, et al. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986;17(4):738–43.
   PubMed Web of Science ®Google Scholar
• Tsai PT, Ohab JJ, Kertesz N, et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 2006;26(4):1269–74.
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17(3):472–6.
   PubMed Web of Science ®Google Scholar
• Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10(2):290–3.
   PubMed Web of Science ®Google Scholar
• Gensch C, Clever Y, Werner C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis. J Mol Cell Cardiol 2007;42(3):670–7.
   PubMed Web of Science ®Google Scholar
• Marchesi S, Pasqualini L, Lombardini R, et al. Prostaglandin E1 improves endothelial function in critical limb ischemia. J Cardiovasc Pharmacol 2003;41(2):249–53.
   PubMed Web of Science ®Google Scholar
• Mehrabi MR1, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease. Cardiovasc Res 2002;56(2):214–24.
   PubMed Web of Science ®Google Scholar
• Haider DG, Bucek RA, Giurgea AG, et al. PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. Am J Physiol Heart Circ Physiol 2005;289(5):H2066–72.
   PubMed Web of Science ®Google Scholar
• Weiss TW, Mehrabi MR, Kaun C, et al. Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism. J Mol Cell Cardiol 2004;36(4):539–46.
   PubMed Web of Science ®Google Scholar
• Lu L, Pelus LM, Piacibello W, et al. Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells. Exp Hematol 1987;15(7):765–71.
   PubMed Web of Science ®Google Scholar
• Najafpour A, Mohammadi R, Faraji D, et al. Local administration of prostaglandin E1 combined with silicone chamber improves peripheral nerve regeneration. Int J Surg 2013;11(9):1010–5.
   PubMed Web of Science ®Google Scholar
• Ohab JJ, Fleming S, Blesch A, et al. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006;26(50):13007–16.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shim SK, Kim HA, et al. CXC chemokine receptor 4 is essential for Lipo-PGE1-enhanced migration of human dermal fibroblasts. Exp Dermatol 2012;21 (1):75–7.
   PubMed Web of Science ®Google Scholar
• Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004;101(52):18117–22.
   PubMed Web of Science ®Google Scholar
• Masjkur J, Rueger MA, Bornstein SR, et al. Neurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vessels. CNS Neurol Disord Drug Targets. 2012;11(7):805–17.
   PubMed Web of Science ®Google Scholar
• Kojima T, Hirota Y, Ema M, et al. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells 2010;28(3):545–54.
   PubMed Web of Science ®Google Scholar